Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of severe, chronic hand eczema: results from a UK-wide survey.
Smith IL, Brown S, Nixon J, Cowdell FC, Ersser S, Fernandez C, Goodfield M, Green CM, Hampton P, Lear JT, Smith CH, Sunderland L, Tubeuf S, Wittmann M. Smith IL, et al. Among authors: hampton p. Clin Exp Dermatol. 2017 Mar;42(2):185-188. doi: 10.1111/ced.13015. Epub 2016 Dec 2. Clin Exp Dermatol. 2017. PMID: 27910127 Free article.
An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema.
Brass D, Fouweather T, Stocken DD, Macdonald C, Wilkinson J, Lloyd J, Farr PM, Reynolds NJ, Hampton PJ. Brass D, et al. Among authors: hampton pj. Br J Dermatol. 2018 Jul;179(1):63-71. doi: 10.1111/bjd.16238. Epub 2018 Mar 14. Br J Dermatol. 2018. PMID: 29235664 Free article. Clinical Trial.
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.
Yiu ZZN, Mason KJ, Barker JNWN, Hampton PJ, McElhone K, Smith CH, Warren RB, Griffiths CEM, Lunt M, Burden AD; BADBIR Study Group. Yiu ZZN, et al. Among authors: hampton pj. Br J Dermatol. 2019 Dec;181(6):1265-1271. doi: 10.1111/bjd.17849. Epub 2019 Jul 2. Br J Dermatol. 2019. PMID: 30822358 Free PMC article.
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, Smith CH, Lunt M, Griffiths CEM, Warren RB; BADBIR Study Group. Yiu ZZN, et al. Among authors: hampton pj. Br J Dermatol. 2020 Aug;183(2):294-302. doi: 10.1111/bjd.18981. Epub 2020 Mar 30. Br J Dermatol. 2020. PMID: 32124442
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators Register.
Yiu ZZN, Mason KJ, Hampton PJ, Reynolds NJ, Smith CH, Lunt M, Griffiths CEM, Warren RB; BADBIR Study Group. Yiu ZZN, et al. JAMA Dermatol. 2021 Jan 1;157(1):66-73. doi: 10.1001/jamadermatol.2020.4202. JAMA Dermatol. 2021. PMID: 33263718 Free PMC article.
Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial.
Smith IL, Gilberts R, Brown S, Fernandez C, Nixon J, Reynolds C, Smith C, Lear JT, Sunderland L, Green C, Goodfield M, Cowdell F, Hampton P, Barker A, Vargas-Palacios A, Tubeuf S, Wittmann M. Smith IL, et al. Among authors: hampton p. BMJ Open. 2022 Feb 23;12(2):e060029. doi: 10.1136/bmjopen-2021-060029. BMJ Open. 2022. PMID: 35197358 Free PMC article.
117 results